213 related articles for article (PubMed ID: 10874208)
1. Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice.
Morikawa T; Wanibuchi H; Morimura K; Ogawa M; Fukushima S
Jpn J Cancer Res; 2000 Jun; 91(6):579-81. PubMed ID: 10874208
[TBL] [Abstract][Full Text] [Related]
2. Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis.
Feith DJ; Shantz LM; Pegg AE
Cancer Res; 2001 Aug; 61(16):6073-81. PubMed ID: 11507056
[TBL] [Abstract][Full Text] [Related]
3. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
Verma AK; Boutwell RK
Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
[TBL] [Abstract][Full Text] [Related]
4. Conversion of C57Bl/6 mice from a tumor promotion-resistant to a -sensitive phenotype by enhanced ornithine decarboxylase expression.
Guo Y; Zhao J; Sawicki J; Peralta Soler A; O'Brien TG
Mol Carcinog; 1999 Sep; 26(1):32-6. PubMed ID: 10487519
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of a dominant-negative ornithine decarboxylase in mouse skin: effect on enzyme activity and papilloma formation.
Shantz LM; Guo Y; Sawicki JA; Pegg AE; O'Brien TG
Carcinogenesis; 2002 Apr; 23(4):657-64. PubMed ID: 11960919
[TBL] [Abstract][Full Text] [Related]
6. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin.
Smith MK; Trempus CS; Gilmour SK
Carcinogenesis; 1998 Aug; 19(8):1409-15. PubMed ID: 9744537
[TBL] [Abstract][Full Text] [Related]
7. K6/ODC transgenic mice as a sensitive model for carcinogen identification.
Chen Y; Megosh LC; Gilmour SK; Sawicki JA; O'Brien TG
Toxicol Lett; 2000 Jul; 116(1-2):27-35. PubMed ID: 10906419
[TBL] [Abstract][Full Text] [Related]
8. Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion-sensitive and promotion-resistant genetic backgrounds.
Feith DJ; Shantz LM; Shoop PL; Keefer KA; Prakashagowda C; Pegg AE
Mol Carcinog; 2007 Jun; 46(6):453-65. PubMed ID: 17219416
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
[TBL] [Abstract][Full Text] [Related]
10. Mouse skin ornithine decarboxylase induction and tumor promotion by cyclohexane.
Gupta KP; Mehrotra NK
Cancer Lett; 1990 Jun; 51(3):227-33. PubMed ID: 2112424
[TBL] [Abstract][Full Text] [Related]
11. Induction of mouse epidermal ornithine decarboxylase activity and skin tumors by 7,12-dimethylben.
Verma AK; Conrad EA; Boutwell RK
Carcinogenesis; 1980 Jul; 1(7):607-11. PubMed ID: 11219836
[TBL] [Abstract][Full Text] [Related]
12. Polyamines modulate carcinogen-induced mutagenesis in vivo.
Wallon UM; O'Brien TG
Environ Mol Mutagen; 2005; 45(1):62-9. PubMed ID: 15611981
[TBL] [Abstract][Full Text] [Related]
13. Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice.
Afaq F; Saleem M; Krueger CG; Reed JD; Mukhtar H
Int J Cancer; 2005 Jan; 113(3):423-33. PubMed ID: 15455341
[TBL] [Abstract][Full Text] [Related]
14. Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
Guo Y; Cleveland JL; O'Brien TG
Cancer Res; 2005 Feb; 65(4):1146-9. PubMed ID: 15734996
[TBL] [Abstract][Full Text] [Related]
15. 3'-Hydroxypterostilbene Inhibits 7,12-Dimethylbenz[a]anthracene (DMBA)/12-O-Tetradecanoylphorbol-13-Acetate (TPA)-Induced Mouse Skin Carcinogenesis.
Lee PS; Chiou YS; Chou PY; Nagabhushanam K; Ho CT; Pan MH
Phytomedicine; 2021 Jan; 81():153432. PubMed ID: 33310310
[TBL] [Abstract][Full Text] [Related]
16. Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility.
Imamoto A; Beltrán LM; Fujiki H; Chenicek KJ; DiGiovanni J
Carcinogenesis; 1992 Feb; 13(2):177-82. PubMed ID: 1740006
[TBL] [Abstract][Full Text] [Related]
17. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin.
Perchellet JP; Abney NL; Thomas RM; Guislain YL; Perchellet EM
Cancer Res; 1987 Jan; 47(2):477-85. PubMed ID: 3098411
[TBL] [Abstract][Full Text] [Related]
18. The utility of the K6/ODC transgenic mouse as an alternative short term dermal model for carcinogenicity testing of pharmaceuticals.
Miller TJ; Honchel R; Espandiari P; Knapton A; Zhang J; Sistare FD; Hanig JP
Regul Toxicol Pharmacol; 2008 Feb; 50(1):87-97. PubMed ID: 18069108
[TBL] [Abstract][Full Text] [Related]
19. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin.
O'Brien TG; Megosh LC; Gilliard G; Soler AP
Cancer Res; 1997 Jul; 57(13):2630-7. PubMed ID: 9205069
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of Ocimum sanctum on 3-methylcholanthrene, 7,12-dimethylbenz(a)anthracene and aflatoxin B1 induced skin tumorigenesis in mice.
Rastogi S; Shukla Y; Paul BN; Chowdhuri DK; Khanna SK; Das M
Toxicol Appl Pharmacol; 2007 Nov; 224(3):228-40. PubMed ID: 17669454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
